Adrenal Insufficiency is Not a Barrier to OCS Elimination in the PONENTE Study

Mark Gurnell, Andrew Menzies-Gow, Liam G Heaney, Jonathan Corren, Elisabeth H Bel, Jorge F Maspero, Timothy Harrison, David Jackson, David Price, Njira Lugogo, James Kreindler, Annie Burden, Alex de Giorgio-Miller, Kelly Padilla, Ubaldo J. Martin, Esther Garcia Gil

Research output: Contribution to journalAbstractpeer-review

3 Downloads (Pure)

Abstract

Oral corticosteroid (OCS) dependence is prevalent in severe asthma and causes
adverse effects, including adrenal insufficiency (AI).
Original languageEnglish
Article numberA1472
Number of pages1
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume203
Early online date19 May 2021
DOIs
Publication statusPublished - 2021
EventATS International Conference Committee: ATS 2021 - Virtual event
Duration: 14 May 202119 May 2021
https://conference.thoracic.org/

Fingerprint

Dive into the research topics of 'Adrenal Insufficiency is Not a Barrier to OCS Elimination in the PONENTE Study'. Together they form a unique fingerprint.

Cite this